Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 2, 2010, Pages 930-938

  Yenikaya, Cengiz ^a   Sari, Musa ^b   Bülbül, Metin ^a   Ilkimen, Halil ^a   Çelik, Hülya ^a   Büyükgüngör, Orhan ^c  

^a DUMLUPINAR UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

2,4 Dichloro 5 sulfamoylbenzoic acid; 2 Amino 3 methylpyridine; Crystal structure; Glaucoma; Inhibition; Proton transfer; Zn(II) complex

Indexed keywords

2 AMINOMETHYLPYRIDINE; 2,4 DICHLORO 5 SULFAMOYLBENZOIC ACID; ACETAZOLAMIDE; ANTIGLAUCOMA AGENT; BIS(2,4 DICHLORO 5 SULFAMOYLBENZOATE)(2 AMINOMETHYLPYRIDINE)AQUAZINC MONOHYDRATE; CARBONATE DEHYDRATASE I; ESTERASE; HYDROLYASE; LIGAND; PYRIDIN 2 YLMETHANAMINIUM 2,4 DICHLORO 5 SULFAMOYLBENZOATE; UNCLASSIFIED DRUG; ZINC COMPLEX; ZINC ION;

AFFINITY CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG SYNTHESIS; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; GLAUCOMA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; PROTON TRANSPORT; THERMAL ANALYSIS; ULTRAVIOLET IRRADIATION; X RAY DIFFRACTION;

CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASE INHIBITORS; CRYSTALLOGRAPHY, X-RAY; ERYTHROCYTES; GLAUCOMA; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; ORGANOMETALLIC COMPOUNDS; PROTONS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE; ZINC;

EID: 76449116293     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.11.031     Document Type: Article

References (59)

1. Supuran C.T., Casini A., Mastrolorenzo A., and Scozzafava A. Mini-Rev. Med. Chem. 4 (2004) 625
2. Owa T., and Nagasu T. Expert Opin. Ther. Patents 10 (2000) 1725
3. Scozzafava A., Owa T., Mastrolorenzo A., and Supuran C.T. Curr. Med. Chem. 10 (2003) 925
4. Choan Z.H., Hassan M., Khan M.K., and Supuran C.T. J. Enzyme Inhib. Med. Chem. 20 (2005) 183
5. Supuran C.T. Nat. Rev. Drug Disc. 7 (2008) 168
6. Bülbül M., Saracoǧlu N., Küfrevioǧlu O.I., and Çiftci M. Bioorg. Med. Chem. 10 (2002) 2561
7. Bülbül M., Kasi{dotless}moǧullari{dotless} R., and Küfrevioǧlu O.I. J. Enzyme Inhib. Med. Chem. 23 (2008) 895
8. Nuti E., Orlandini E., Nencetti S., Rossello A., Innocenti A., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. 15 (2007) 2298
9. Özensoy O., Koçkar F., Arslan O., Işi{dotless}k S., Supuran C.T., and Lyon M. Clin. Biochem. 40 (2007) 835
10. Supuran C.T., and Scozzafava A. Bioorg. Med. Chem. 15 (2007) 4336
11. Di Fiore A., Scozzafava A., Winum J.Y., Montero J.L., Pedone C., Supuran C.T., and Simone G.D. Bioorg. Med. Chem. Lett. 17 (2007) 1726
12. Innocenti A., Vullo D., Pastorek J., Scozzafava A., Pastorekova S., Nishimori I., and Supuran C.T. Bioorg. Med. Chem. Lett. 17 (2007) 1532
13. Winum J.Y., Thiry A., Cheikh K.E., Dogne J.M., Montero J.L., Vullo D., Scozzafava A., Masereel B., and Supuran C.T. Bioorg. Med. Chem. Lett. 17 (2007) 2685
14. Scozzafava A., Banciu M.D., Popescu A., and Supuran C.T. J. Enzyme Inhib. Med. Chem. 15 (2000) 443
15. Schuman J.S. Clin. Ther. 22 (2000) 2
16. Wilkinson B.L., Bornaghi L.F., Houston T.A., Innocenti A., Vullo D., Supuran C.T., and Poulsen S.A. Bioorg. Med. Chem. Lett. 17 (2007) 987
17. Santos M.A., Marques S., Vullo D., Innocenti A., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 17 (2007) 1538
18. Karami S., Li Y., Hughes D.S., Hursthouse M.B., Russell A.E., Threlfall T.L., Claybourn M., and Roberts R. Acta Crystallogr., Sect. B 62 (2006) 689
19. Latosińska J.N., Latosińska M., and Medycki W. J. Mol. Struct. 931 (2009) 94
20. Kefi R., Nasr C.B., Lefebvre F., and Durif A. Inorg. Chim. Acta 358 (2005) 4075
21. Tanase S., Ferbinteanu M., Andruh M., Mathonière C., Strenger I., and Rombaut G. Polyhedron 19 (2000) 1967
22. Paraschiv C., Andruh M., and Sutter J.P. Inorg. Chim. Acta 351 (2003) 385
23. Zhu T., Guang-Yi Z., Xue-Qiang L., Sai-Feng X., Qian-Jiang Z., Jackson W.G., Zhan-Bing W., and La-Sheng L. Inorg. Chim. Acta 357 (2004) 953
24. Wu Y.F., Song Y., Shen K., Shen Z., Shen X., Xu Y., and Zhu D.-R. Inorg. Chem. Commun. 12 (2009) 959
25. Yenikaya C., Poyraz M., Sari{dotless} M., Demirci F., İlkimen H., and Büyükgüngör O. Polyhedron 28 (2009) 3526
26. Malassa A., Görls H., and Westerhausen M. Inorg. Chem. Commun. 11 (2008) 612
27. Spiccia L., Deacon G.B., and Kepert C.M. Coord. Chem. Rev. 248 (2004) 1329
28. Lechat P., Tesleff S., and Bownan W.C. Aminopyridines and Similarly Acting Drugs (1982), Pergamon, Oxford
29. Queiroz M.J.R.P., Ferreira I.C.F.R., Calhelha R.C., and Estevinho L.M. Bioorg. Med. Chem. 15 (2007) 1788
30. Bertini I., Luchinat C., Maret W., and Zeppezauer M. Progress in Inorganic Biochemistry and Biophysics (1986), Birkhauser, Boston, MA 1
31. Vallee B.L., and Galdes A. Adv. Enzymol. Relat. Areas Mol. Biol. 56 (1984) 283
32. Sigel H. Ions in Biological Systems (1993), Dekker, New York
33. Sheldrick, G. M. shelxs97 AND SHEXL97. Program for Crystal Structure Solution and Refinement. University of Göttingen: Germany, 1997.
34. Stoe & Cie, X-AREA (Version 1.18) and X-RED32 (Version 1.04). Stoe & Cie, Darmstadt, Germany, 2002.
35. Farrugia L.J. J. Appl. Crystallogr. 30 (1997) 565
36. Arslan O., Nalbantoǧlu B., Demir N., Özdemir H., and Küfrevioǧlu O.I. Trop. J. Med. Sci. 26 (1996) 163
37. Rickli E.E., Ghazanfar S.A., Gibbson B.H., and Edsall J.T. J. Biol. Chem. 239 (1964) 1065
38. Bradford M.M. Anal. Biochem. 72 (1976) 248
39. Laemmli D.K. Nature 227 (1970) 680
40. Wilbur K.M., and Anderson N.G. J. Biol. Chem. 176 (1976) 147
41. Verpoorte J.A., Mehta S., and Edsall J.T. J. Biol. Chem. 242 (1967) 4221
42. Innocenti A., Scozzafava A., Parkkila S., Pucceti L., De Simone G., and Supuran C.T. Bioorg. Med. Chem. Lett. 18 (2008) 2267
43. Landolfi C., Marchetti M., Ciocci G., and Milanese C. J. Pharmacol. Toxicol. Methods 38 (1998) 169
44. Bülbül M., Hisar O., Beydemir S., Ciftci M., and Küfrevioǧlu O.I. J. Enzyme Inhib. Med. Chem. 18 (2003) 371
45. Ciftci M., Bülbül M., Gül M., Gümüştekin K., Dane S., and Süleyman H. J. Enzyme Inhib. Med. Chem. 20 (2005) 103
46. Hisar O., Beydemir S., Bülbül M., and Yani{dotless}k T. J. Appl. Anim. Res. 30 (2006) 185
47. Winum J.Y., Cecchi A., Montero J.L., Innocenti A., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 15 (2005) 3302
48. Lanznaster M., Neves A., Vencato I., Bortoluzzi A.J., Gallardo H., Machado S.P., and Assumpçāo M.C. J. Braz. Chem. Soc. 17 (2006) 289
49. Neves A., and Vencato C.N. J. Braz. Chem. Soc. 8 (1997) 265
50. Correia V.R., Bortoluzzi A.J., Neves A., Joussef A.C., Vieira M.G.M., and Batista S.C. Acta Crystallogr., Sect. E 59 (2003) m464
51. Adams H., Bradshaw D., and Fenton D.E. Eur. J. Inorg. Chem. (2001) 859
52. Adams H., Bradshaw D., Collison D., and Fenton D.E. Inorg. Chem. Commun. 4 (2001) 664
53. Nakamoto K. Infrared And Raman Spectra of İnorganic and Coordination Compounds. 5th ed. (1997), Interscience-Wiley, New York p 16
54. Gowda B.T., Jyothi K., and Souza J.D.D. Z. Naturforsch. 57a (2002) 967
55. Nakamoto K. Infrared And Raman Spectra of İnorganic and Coordination Compounds. 5th ed. (1997), Interscience-Wiley, New York p 59
56. Mao L., Wang Y., Qi Y., Cao M., and Hu C. J. Mol. Struct. 688 (2004) 197
57. Uçar I., Karabulut B., Bulut A., and Büyükgüngör O. J. Mol. Struct. 336 (2007) 834
58. Kirillova M.V., Da Silva M.F.C.G., Kirillov A.M., Da Silva J.J.R.F., and Pombeiro A.J.L. Inorg. Chim. Acta 360 (2007) 506
59. Geary W.J. Coord. Chem. Rev. (1971) 781